Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2025-12-17 @ 7:13 AM
Study NCT ID:
NCT05876364
Status:
None
Last Update Posted:
2023-05-25 00:00:00
First Post:
2023-05-01 00:00:00
Brief Title:
Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)
Sponsor:
Quratis Inc
Organization:
Quratis Inc.